Nanovaccines against Viral Infectious Diseases
Infectious diseases have always been regarded as one of the greatest global threats for the last century. The current ongoing COVID-19 pandemic caused by SARS-CoV-2 is living proof that the world is still threatened by emerging infectious diseases. Morbidity and mortality rates of diseases caused by...
Saved in:
Main Authors: | Heng, Wen Tzuen *, Yew, Jia Sheng *, Poh, Chit Laa * |
---|---|
Format: | Article |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/2934/ https://doi.org/10.3390/pharmaceutics14122554 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria
by: Kanwal, Khalid *, et al.
Published: (2023) -
In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012) -
The development of DNA vaccines against SARS-CoV-2
by: Kanwal, Khalid *, et al.
Published: (2023) -
Development of virus-like particles-based vaccines against
by: Yong, Chean Yeah, et al.
Published: (2022) -
Inhibition of Enterovirus 71 (EV-71 infections by a novel
antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)